CHEN, Wei,MOORE, Paul, A.,PANDYA, Naimish, Bharat,BONVINI, Ezio,WIGGINTON, Jon Marc
申请号：
EP17810826
公开号：
EP3464378A4
申请日:
2017.06.06
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention is directed to methods for using bispecific binding molecules that possess a binding site specific for an epitope of CD32B and a binding site specific for an epitope of CD79B, and are thus capable of simultaneous binding to CD32B and CD79B. The invention particularly concerns such molecules that are bispecific antibodies or bispecific diabodies (and especially such diabodies that additionally comprise an Fc Domain). The invention is directed to the use of such molecules, and to the use of pharmaceutical compositions that contain such molecules in the treatment of inflammatory diseases or conditions.
